drugset / Trial / NCT00902668

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

NCT00902668

Phase 2 Terminated 3 enrolled Virginia Commonwealth University
NaSingle-groupOpen-labelSupportive care

Summary

RATIONALE: Drugs, such as lovastatin, may protect normal cells from the side effects of radiation therapy. PURPOSE: This phase II trial is studying how well lovastatin works in reducing side effects after radiation therapy in women with breast cancer.

Timeline

Start
2009-04
Primary completion
2011-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovastatin Small molecule Oral